Skip to main content
Top
Published in: Diabetes Therapy 2/2015

Open Access 01-06-2015 | Original Research

Experiences of People with Diabetes by Payer Type: An Analysis of the Roper Diabetes Data Set

Authors: Susan S. Garfield, Jason J. Xenakis, Alex Bastian, Mary McBride

Published in: Diabetes Therapy | Issue 2/2015

Login to get access

Abstract

Introduction

The study details the experiences of Medicare, Medicaid and privately insured patients with diabetes in the United States by focusing on how these distinct populations perceive their disease and manage their treatment.

Methods

A national survey was fielded among a representative sample of 2,307 US adult diagnosed diabetes patients to investigate demographic, lifestyle, treatment, access to information, and socioeconomic status. This was achieved using a combination of telephone-based interviews and internet-based questionnaires administered via KnowledgePanel®, the only large-scale online panel based on a representative random sample of the US population.

Results

Patients with Medicaid-based insurance face significant differences in diagnosis, treatment and intensity of their diabetes as compared to their Medicare and privately insured counterparts. Medicaid patients develop diabetes at an earlier age with an increased level of severity, and face significant socioeconomic concerns. Medicaid patients also have different health information seeking preferences than their counterparts, impacted by technology use patterns and education preferences. All groups report challenges in paying for their diabetes care, though cost-sharing requirements are relatively low.

Conclusions

Significant variation in experience between Medicaid, Medicare, and privately insured patients can inform disease management and patient engagement strategies. Payers, clinicians and public health agencies can leverage these findings to design initiatives more effectively and understand how intergroup variability impacts program uptake and disease outcomes.
Appendix
Available only for authorised users
Literature
3.
go back to reference American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabet Care. 2013;36:1033–46.CrossRef American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabet Care. 2013;36:1033–46.CrossRef
4.
go back to reference Kim S. Burden of hospitalizations primarily due to uncontrolled diabetes. Diabet Care. 2007;30(5):1281–2.CrossRef Kim S. Burden of hospitalizations primarily due to uncontrolled diabetes. Diabet Care. 2007;30(5):1281–2.CrossRef
5.
go back to reference Brown J, Pedula K, Bakst A. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med. 1999;159(16):1873–80.PubMedCrossRef Brown J, Pedula K, Bakst A. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med. 1999;159(16):1873–80.PubMedCrossRef
7.
go back to reference American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2014;37(Suppl 1):S14–80.CrossRef American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2014;37(Suppl 1):S14–80.CrossRef
8.
go back to reference Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, Fisher EB, Hanson L, Kent D, Kolb L, McLaughlin S, Orzeck E, Piette JD, Rhinehart AS, Rothman R, Sklaroff S, Tomky D. Youssef G; 2012 Standards Revision Task Force. National Standards for Diabetes Self-Management Education and Support. Diabetes Care. 2014;37(Suppl 1):S144–53.PubMedCentralPubMedCrossRef Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, Fisher EB, Hanson L, Kent D, Kolb L, McLaughlin S, Orzeck E, Piette JD, Rhinehart AS, Rothman R, Sklaroff S, Tomky D. Youssef G; 2012 Standards Revision Task Force. National Standards for Diabetes Self-Management Education and Support. Diabetes Care. 2014;37(Suppl 1):S144–53.PubMedCentralPubMedCrossRef
10.
go back to reference Shaw K, Killeen M, Sullivan E, Bowman P. Disparities in diabetes self-management education for uninsured and underinsured adults. Diabet Edu. 2011;37:813.CrossRef Shaw K, Killeen M, Sullivan E, Bowman P. Disparities in diabetes self-management education for uninsured and underinsured adults. Diabet Edu. 2011;37:813.CrossRef
11.
go back to reference Richard P, Alexandre PK, Lara A, Akamigbo AB. Racial and ethnic disparities in the quality of diabetes care in a nationally representative sample. Prev Chronic Dis. 2011;8(6):A142.PubMedCentralPubMed Richard P, Alexandre PK, Lara A, Akamigbo AB. Racial and ethnic disparities in the quality of diabetes care in a nationally representative sample. Prev Chronic Dis. 2011;8(6):A142.PubMedCentralPubMed
13.
go back to reference Briesacher B, Limcangco R, Gaskin D. Racial and Ethnic Disparities in prescription Coverage and Medication Use. Health Care Financ Rev Winter. 2003;25(2):63–76. Briesacher B, Limcangco R, Gaskin D. Racial and Ethnic Disparities in prescription Coverage and Medication Use. Health Care Financ Rev Winter. 2003;25(2):63–76.
14.
go back to reference Hu R, Shi L, Rane S, Zhu J, Chen CC. Insurance, racial/ethnic, ses-related disparities in quality of care among US adults with diabetes. J Immigrant Minor Health. 2014;16(4):565–75.CrossRef Hu R, Shi L, Rane S, Zhu J, Chen CC. Insurance, racial/ethnic, ses-related disparities in quality of care among US adults with diabetes. J Immigrant Minor Health. 2014;16(4):565–75.CrossRef
16.
go back to reference Chang T, Davis M. Potential adult medicaid beneficiaries under the patient protection and affordable care act compared with current adult medicaid beneficiaries. Annal Family Med. 2013;11(5):406–11.CrossRef Chang T, Davis M. Potential adult medicaid beneficiaries under the patient protection and affordable care act compared with current adult medicaid beneficiaries. Annal Family Med. 2013;11(5):406–11.CrossRef
17.
go back to reference Dudley B, Heiland B, Kohler-Rausch E, Kovic M. Education and technology used to improve the quality of life for people with diabetes mellitus type II. J Multidiscip Health. 2014;7:147–53.CrossRef Dudley B, Heiland B, Kohler-Rausch E, Kovic M. Education and technology used to improve the quality of life for people with diabetes mellitus type II. J Multidiscip Health. 2014;7:147–53.CrossRef
18.
go back to reference O’Reilly DJ, Bowen JM, Sebaldt RJ, et al. Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational study. Ontario Health Technol Assess Ser. 2014;14(3):1–37. O’Reilly DJ, Bowen JM, Sebaldt RJ, et al. Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational study. Ontario Health Technol Assess Ser. 2014;14(3):1–37.
19.
go back to reference Breland J, Yeh V, Yu J. Adherence to evidence-based guidelines among diabetes self-management apps. TBM. 2013;3:227–86. Breland J, Yeh V, Yu J. Adherence to evidence-based guidelines among diabetes self-management apps. TBM. 2013;3:227–86.
20.
go back to reference El-Gayar O, Timsina P, Nawar N, Eid W. A systematic review of IT for diabetes self-management: are we there yet? Int J Med Informatics. 2013;82(8):637–52.CrossRef El-Gayar O, Timsina P, Nawar N, Eid W. A systematic review of IT for diabetes self-management: are we there yet? Int J Med Informatics. 2013;82(8):637–52.CrossRef
21.
go back to reference El-Gayar O, Timsina P, Nawar N, Eid W. Mobile applications for diabetes self-management: status and potential. J Diabet Sci Technol. 2013;7(1):247–62.CrossRef El-Gayar O, Timsina P, Nawar N, Eid W. Mobile applications for diabetes self-management: status and potential. J Diabet Sci Technol. 2013;7(1):247–62.CrossRef
23.
go back to reference Phisitkul K, Hegazy K, Chuahirun T, Hudson C, Simoni J, Rajab H, Wesson DE. Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy. Am J Med Sci. 2008;335(4):284–91.PubMedCrossRef Phisitkul K, Hegazy K, Chuahirun T, Hudson C, Simoni J, Rajab H, Wesson DE. Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy. Am J Med Sci. 2008;335(4):284–91.PubMedCrossRef
24.
go back to reference Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Wedel H. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New Eng J Med. 2004;351(26):2683–93.PubMedCrossRef Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Wedel H. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New Eng J Med. 2004;351(26):2683–93.PubMedCrossRef
25.
go back to reference Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Tuomilehto J. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish diabetes prevention study. Lancet. 2006;368(9548):1673–9.PubMedCrossRef Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Tuomilehto J. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish diabetes prevention study. Lancet. 2006;368(9548):1673–9.PubMedCrossRef
26.
go back to reference Mulhem E, Lick D, Varughese J, Barton E, Ripley T, Haveman J. Adherence to medications after hospital discharge in the Elderly. Int J of Family Med. 2013;2013:901845.CrossRef Mulhem E, Lick D, Varughese J, Barton E, Ripley T, Haveman J. Adherence to medications after hospital discharge in the Elderly. Int J of Family Med. 2013;2013:901845.CrossRef
Metadata
Title
Experiences of People with Diabetes by Payer Type: An Analysis of the Roper Diabetes Data Set
Authors
Susan S. Garfield
Jason J. Xenakis
Alex Bastian
Mary McBride
Publication date
01-06-2015
Publisher
Springer Healthcare
Published in
Diabetes Therapy / Issue 2/2015
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-015-0109-z

Other articles of this Issue 2/2015

Diabetes Therapy 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.